chr12-7209754-G-A

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001351132.2(PEX5):​c.1632G>A​(p.Ala544=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00144 in 1,571,076 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A544A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0080 ( 8 hom., cov: 32)
Exomes 𝑓: 0.00091 ( 8 hom. )

Consequence

PEX5
NM_001351132.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -8.53
Variant links:
Genes affected
PEX5 (HGNC:9719): (peroxisomal biogenesis factor 5) The product of this gene binds to the C-terminal PTS1-type tripeptide peroxisomal targeting signal (SKL-type) and plays an essential role in peroxisomal protein import. Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. The peroxisomal biogenesis disorders are a heterogeneous group with at least 14 complementation groups and with more than 1 phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause of neonatal adrenoleukodystrophy (NALD), a cause of Zellweger syndrome (ZWS) as well as may be a cause of infantile Refsum disease (IRD). Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 12-7209754-G-A is Benign according to our data. Variant chr12-7209754-G-A is described in ClinVar as [Benign]. Clinvar id is 257546.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-8.53 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00798 (950/119090) while in subpopulation AFR AF= 0.0272 (883/32448). AF 95% confidence interval is 0.0257. There are 8 homozygotes in gnomad4. There are 482 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PEX5NM_001351132.2 linkuse as main transcriptc.1632G>A p.Ala544= synonymous_variant 15/16 ENST00000675855.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PEX5ENST00000675855.1 linkuse as main transcriptc.1632G>A p.Ala544= synonymous_variant 15/16 NM_001351132.2 A1P50542-1

Frequencies

GnomAD3 genomes
AF:
0.00803
AC:
956
AN:
119014
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0274
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00261
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00102
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000129
Gnomad MID
AF:
0.00382
Gnomad NFE
AF:
0.000312
Gnomad OTH
AF:
0.00954
GnomAD3 exomes
AF:
0.00197
AC:
496
AN:
251466
Hom.:
3
AF XY:
0.00141
AC XY:
192
AN XY:
135912
show subpopulations
Gnomad AFR exome
AF:
0.0235
Gnomad AMR exome
AF:
0.00162
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000435
Gnomad SAS exome
AF:
0.0000980
Gnomad FIN exome
AF:
0.000416
Gnomad NFE exome
AF:
0.000255
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.000909
AC:
1320
AN:
1451986
Hom.:
8
Cov.:
34
AF XY:
0.000777
AC XY:
561
AN XY:
722322
show subpopulations
Gnomad4 AFR exome
AF:
0.0220
Gnomad4 AMR exome
AF:
0.00185
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000283
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.000228
Gnomad4 NFE exome
AF:
0.000342
Gnomad4 OTH exome
AF:
0.00156
GnomAD4 genome
AF:
0.00798
AC:
950
AN:
119090
Hom.:
8
Cov.:
32
AF XY:
0.00833
AC XY:
482
AN XY:
57880
show subpopulations
Gnomad4 AFR
AF:
0.0272
Gnomad4 AMR
AF:
0.00252
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00103
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000129
Gnomad4 NFE
AF:
0.000312
Gnomad4 OTH
AF:
0.00939
Alfa
AF:
0.00207
Hom.:
2
Bravo
AF:
0.00695
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.000327
EpiControl
AF:
0.000237

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Peroxisome biogenesis disorder 2B Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Peroxisome biogenesis disorder 2A (Zellweger) Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.042
DANN
Benign
0.58

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs115338343; hg19: chr12-7362350; API